Recent developments in the field of obesity treatment have presented a new drug known as ALLUVI Retatrutide. This substance is a {highlyspecific GLP-1 receptor agonist, formulated to stimulate the effects of natural glucagon-like peptide-1. Retatrutide has shown impressive efficacy in clinical trials, highlighting significant decreases in body weig